article thumbnail

STAT+: Belgian anti-trust authorities probe Roche for allegedly delaying biosimilars of two cancer meds

STAT

In a brief statement , the Belgian Competition Authority alleged that Roche offered financial incentives to hospitals between 2017 and 2020 to deter them from considering competitive bids from other pharmaceutical companies that could supply similar medicines.

article thumbnail

Medical malpractice lawsuits, delayed by the pandemic, are hitting hospitals harder than expected

STAT

Carlos David Castro Rojas was a healthy 27-year-old engineering student when he fell off a ladder hanging Christmas lights in 2017, breaking his leg and injuring his knee. 

Hospitals 246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: RaDonda Vaught, former Vanderbilt nurse who accidentally killed patient, says hospital issues contributed, too

STAT

Her closely watched trial centered on both the human errors and the shortcomings at Vanderbilt University Medical Center that may have contributed to the 75-year-old patient’s death in 2017. But in her Zoom presentation on Tuesday , Vaught spent more time emphasizing the latter.

Hospitals 327
article thumbnail

STAT+: FDA is still struggling to inspect clinical research sites, watchdog finds

STAT

Food and Drug Administration’s oversight of clinical research in hospitals and clinics has fallen considerably in recent years, due to disruptions caused by the Covid pandemic and challenges finding and keeping investigators, according to a new report by the U.S. By comparison, the FDA inspected 976 clinical study sites in 2017.

Hospitals 333
article thumbnail

STAT+: AbbVie dramatically outspent its pharma company rivals in 2023 to promote its drugs to doctors

STAT

The massive sum spent by AbbVie, the maker of the mega blockbuster anti-inflammatory drug Humira, is the most a pharmaceutical company has spent on marketing to doctors since such data became available in 2017.

article thumbnail

STAT+: New CAR-T company, Brainchild Bio, will focus first on brain tumors in children

STAT

About a decade ago, Mike Jensen, a pediatric oncologist at Seattle Children’s hospital, licensed to a startup his designs for a powerful new type of therapy, called CAR-T, that would re-engineer a child’s own immune cells to target cancer. The deal proved be a mixed blessing. But it was never approved for childhood cancer. 

Immunity 311
article thumbnail

STAT Wunderkinds discuss high-impact research, resilience, and social justice

STAT

Smith was in STAT’s 2017 class of Wunderkinds , an annual selection of standout researchers who are launching their careers. Now, as a research director at Vertex Pharmaceuticals, she is working on potential sickle cell medicines.